We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C.
- Authors
Siebert, U; Sroczynski, G; Rossol, S; Wasem, J; Ravens-Sieberer, U; Kurth, B M; Manns, M P; McHutchison, J G; Wong, J B; German Hepatitis C Model (GEHMO) Group; International Hepatitis Interventional Therapy (IHIT) Group
- Abstract
Peginterferon alpha-2b plus ribavirin therapy in previously untreated patients with chronic hepatitis C yields the highest sustained virological response rates of any treatment strategy but is expensive.
- Publication
Gut, 2003, Vol 52, Issue 3, p425
- ISSN
0017-5749
- Publication type
Journal Article
- DOI
10.1136/gut.52.3.425